This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Litonjua, M. R. Articles by Daubert, G. P. Search for Related Content Social Bookmarking                   What's this?

Digoxin: The Monarch of Cardiac Toxicities

Detroit Receiving Hospital, Department of Emergency Medicine & Pediatrics, Wayne State University School of Medicine, Detroit, Michigan

Stephanie Penton, MD

Detroit Receiving Hospital, Department of Emergency Medicine & Pediatrics, Wayne State University School of Medicine, Detroit, Michigan

Craig Robinson, MD

Detroit Receiving Hospital, Department of Emergency Medicine & Pediatrics, Wayne State University School of Medicine, Detroit, Michigan

G. Patrick Daubert, MD

Department of Emergency Medicine & Pediatrics, Wayne State University School of Medicine, Detroit, Michigan, gpat-md{at}med.wayne.edu

The cardiac steroids (or glycosides) are a heterogeneous group of compounds that have been well recognized for both their clinical benefit and inherent toxicity. This review will primarily focus on digoxin because of its widespread clinical use, although the other cardiac steroids will be discussed in less detail. The cardiac steroids have a narrow therapeutic index and remain a significant source of toxicity, with nearly 5000 human exposures reported to the American Association of Poison Control Centers in 2002. Digoxin reversibly binds to the subunit of the Na⁺-K⁺ ATPase pump and completely inhibits its enzymatic and transport functions. The cumulative effect on cardiac tissue is dependent on the number of Na⁺-K⁺ATPase pump sites that are occupied by cardiac steroid molecules. It is important to recall the pharmacokinetics of digoxin in that serum digoxin levels drawn prior to tissue distribution (<6 hours) do not accurately reflect acute toxicity. Signs and symptoms of toxicity vary between acute and chronic intoxications. A systematic approach guided by clinical symptoms with early administration of immunotherapy can lead to a significant reduction of morbidity and mortality in digoxin-poisoned patients.

Key Words: Digoxin • cardiac • toxicity • electrocardiogram • immunotherapy

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?